Induction of preferential chemotaxis of unstimulated B-lymphocytes by 2-arachidonoylglycerol in immunized mice

Microbiology and Immunology

Volumn 51, Issue 10, 2007, Pages 1013-1019

  Tanikawa, Takashi ^a   Kurohane, Kohta ^a   Imai, Yasuyuki ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Cannabinoid receptor; Cell migration; Germinal center; Lipid mediator

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CHOLERA TOXIN; IMMUNOGLOBULIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL STRUCTURE; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; IMMUNIZATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; SPLEEN CELL;

MUS;

EID: 35448940523     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2007.tb03985.x     Document Type: Article

References (30)

1. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., Le Fur, G., and Casellas, P. 1993. Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214: 173-180.
2. Buckley, N.E., McCoy, K.L., Mezey, E., Bonner, T., Zimmer, A., Felder, C.C., and Glass, M. 2000. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 396: 141-149.
3. Carayon, P., Marchand, J., Dussossoy, D., Derocq, J.M., Jbilo, O., Bord, A., Bouaboula, M., Galiegue, S., Mondiere, P., Penarier, G., Fur, G.L., Defrance, T., and Casellas, P. 1998. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 92: 3605-3615.
4. Chang, Y.H., Lee, S.T., and Lin, W.W. 2001. Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell Biochem. 81: 715-723.
5. Dalwadi, H., Wei, B., Schrage, M., Spicher, K., Su, T.T., Birnbaumer, L., Rawlings, D.J., and Braun, J. 2003. B cell developmental requirement for the Gαi2 gene. J. Immunol. 170: 1707-1715.
6. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J.A., and Kunos, G. 1999. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264: 258-267.
7. Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., and Hipkin, R.W. 2000. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol. Pharmacol. 57: 1045-1050.
8. Gunn, M.D., Ngo, V.N., Ansel, K.M., Ekland, E.H., Cyster, J.G., and Williams, L.T. 1998. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 391: 799-803.
9. Imai, Y., Fukui, T., Ikegaya, A., Ishikawa, T., Ono, Y., and Kurohane, K. 2002. Lack of Shiga-like toxin binding sites in germinal centres of mouse lymphoid tissues. Immunology 105: 509-514.
10. Jorda, M.A., Verbakel, S.E., Valk, P.J., Vankan-Berkhoudt, Y.V., Maccarrone, M., Finazzi-Agro, A., Lowenberg, B., and Delwel, R. 2002. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99: 2786-2793.
11. Kishimoto, S., Gokoh, M., Oka, S., Muramatsu, M., Kajiwara, T., Waku, K., and Sugiura, T. 2003. 2-Arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J. Biol. Chem. 278: 24469-24475.
12. Kishimoto, S., Muramatsu, M., Gokoh, M., Oka, S., Waku, K., and Sugiura, T. 2005. Endogenous cannabinoid receptor ligand induces the migration of human natural killer cells. J. Biochem. (Tokyo) 137: 217-223.
13. Kobayashi, Y., Arai, S., Waku, K., and Sugiura, T. 2001. Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. J. Biochem. (Tokyo) 129: 665-669.
14. Maestroni, G.J. 2004. The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J. 18: 1914-1916.
15. Matias, I., Pochard, P., Orlando, P., Salzet, M., Pestel, J., and Di Marzo, V. 2002. Presence and regulation of the endocannabinoid system in human dendritic cells. Eur. J. Biochem. 269: 3771-3778.
16. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
17. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50: 83-90.
18. Munro, S., Thomas, K.L., and Abu-Shaar, M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
19. Oka, S., Ikeda, S., Kishimoto, S., Gokoh, M., Yanagimoto, S., Waku, K., and Sugiura, T. 2004. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. J. Leukoc. Biol. 76: 1002-1009.
20. Oka, S., Wakui, J., Ikeda, S., Yanagimoto, S., Kishimoto, S., Gokoh, M., Nasui, M., and Sugiura, T. 2006. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice. J. Immunol. 177: 8796-8805.
21. Oka, S., Yanagimoto, S., Ikeda, S., Gokoh, M., Kishimoto, S., Waku, K., Ishima, Y., and Sugiura, T. 2005. Evidence for the involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation in mouse ear. J. Biol. Chem. 280: 18488-18497.
22. Ouyang, Y., Hwang, S.G., Han, S.H., and Kaminski, N.E. 1998. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol. Pharmacol. 53: 676-683.
23. Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., Portier, M., Shire, D., Breliere, J.C., and Le Fur, G.L. 1998. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284: 644-650.
24. Sanchez, T., and Hla, T. 2004. Structural and functional characteristics of S1P receptors. J. Cell Biochem. 92: 913-922.
25. Shinall, S.M., Gonzalez-Fernandez, M., Noelle, R.J., and Waldschmidt, T.J. 2000. Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J. Immunol. 164: 5729-5738.
26. Steffens, S., Veillard, N.R., Arnaud, C., Pelli, G., Burger, F., Staub, C., Karsak, M., Zimmer, A., Frossard, J.L., and Mach, F. 2005. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 434: 782-786.
27. Sugiura, T., Kondo, S., Kishimoto, S., Miyashita, T., Nakane, S., Kodaka, T., Suhara, Y., Takayama, H., and Waku, K. 2000. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275: 605-612.
28. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. 1995. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215: 89-97.
29. Walter, L., Franklin, A., Witting, A., Wade, C., Xie, Y., Kunos, G., Mackie, K., and Stella, N. 2003. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23: 1398-1405.
30. Ziring, D., Wei, B., Velazquez, P., Schrage, M., Buckley, N.E., and Braun, J. 2006. Formation of B and T cell subsets require the cannabinoid receptor CB2. Immunogenetics 58: 714-725.